JPH0318492B2 - - Google Patents
Info
- Publication number
- JPH0318492B2 JPH0318492B2 JP58107634A JP10763483A JPH0318492B2 JP H0318492 B2 JPH0318492 B2 JP H0318492B2 JP 58107634 A JP58107634 A JP 58107634A JP 10763483 A JP10763483 A JP 10763483A JP H0318492 B2 JPH0318492 B2 JP H0318492B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- hollow fiber
- fiber membrane
- spinning
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Artificial Filaments (AREA)
Description
<技術分野>
本発明は、セルロースエステル中空糸膜の製造
法に関する。さらに詳しくはセルロースアセテー
トを主成分とする中空糸膜であつて、血漿中より
アルブミンを回収することができる所謂血漿アル
ブミン透過性中空糸間の製造法に関するものであ
る。
<従来技術>
近年、中空糸膜を血液浄化を目的とする治療法
が進歩しつつあるが、血漿交換療法もその一つで
ある。
血漿交換療法は患者の血中有害性高分子蛋白を
除去する目的で血漿を分離し、新鮮な健康人の血
漿を注入する療法であり、最近、慢性リユーマ
チ、癌、膠原病などの難治性疾患の治療法として
注目されている。
この治療法は優れた効果が得られているが、新
鮮な血漿を多量に用いるための費用の増大と、肝
炎の感染などの問題が残されている。このため、
患者の分離血漿より免疫複合体や分子量の大きい
蛋白質を除去して、アルブミンを回収することが
出来れば、上記の問題は解決されるわけであり、
現在鋭意研究されている。
かかるアルブミンの回収に多孔性膜の使用が試
みられ、そのための多孔性膜の細孔の孔径は、大
きくとも約0.1μであり、最低0.02μ程度が求めら
れている。
血漿分離膜としては、既にいくつかの特許出願
がみられる。即ちセルロースアセテートを素材と
するものでは、例えば特公昭50−31901号公報に
おいて、多孔フイルムを得る方法として金属塩と
共に各種のアルコール類、エステル類、エーテル
類、環状炭化水素類を溶媒中に添加して製膜する
ことを提案している。
しかしながらこれらの方法は、その実施例でも
明示している如く、細孔の孔径が比較的大きく、
0.1μ以上のものが大部分であり、アルブミン回収
用の膜の製法として必ずしも適当な方法と言えな
い。
<発明の目的>
本発明は、このような患者の血漿よりアルブミ
ンを回収するための中空糸膜を得んとするもので
ある。
即ち、本発明の目的は、血漿よりアルブミンを
効率よく回収するために、平均細孔径が約0.01μ
〜約0.1μ、より望ましくは約0.02μ〜約0.07μのセ
ルロースエステル中空糸膜を有利に製造する方法
を提供することである。
<発明の構成>
本発明者らは、かかる目的を達成すべく鋭意研
究した結果、紡糸原液に溶媒と共に添加する特定
の有機化合物と、得られるセルロースエステル中
空糸膜の細孔の間に特異な関係があることを見出
し、特に塩化カルシウムの共存した紡糸原液を用
いることにより、該中空糸膜の細孔径が0.01〜
0.1μ程度のアルブミン透過性の優れた中空糸膜
が、非常に有利に得られることを見い出し、本発
明に到達し得たものである。
即ち本発明は、下記一般式()
〔但し式()において、R1及びR2は同一又は
異なり水素原子又は炭素数が1〜3であるアルキ
ル基を表わし、R3は水素原子、
<Technical Field> The present invention relates to a method for producing cellulose ester hollow fiber membranes. More specifically, the present invention relates to a method for producing a so-called plasma albumin-permeable hollow fiber membrane, which is a hollow fiber membrane whose main component is cellulose acetate, and which can recover albumin from plasma. <Prior Art> In recent years, therapeutic methods using hollow fiber membranes for the purpose of blood purification have been progressing, and plasma exchange therapy is one of them. Plasma exchange therapy is a therapy in which plasma is separated and fresh healthy plasma is injected to remove harmful high-molecular proteins from the patient's blood. It is attracting attention as a treatment method. Although this treatment method has shown excellent effects, there remain problems such as increased costs due to the use of large amounts of fresh plasma and hepatitis infection. For this reason,
If immune complexes and large molecular weight proteins can be removed from the patient's isolated plasma and albumin can be recovered, the above problems will be solved.
It is currently being intensively researched. Attempts have been made to use porous membranes to recover such albumin, and the pore diameter of the porous membrane for this purpose is approximately 0.1 μ at the most, and approximately 0.02 μ at the minimum. Several patent applications have already been filed for plasma separation membranes. In other words, for products made from cellulose acetate, for example, Japanese Patent Publication No. 31901/1983 discloses a method of obtaining a porous film by adding various alcohols, esters, ethers, and cyclic hydrocarbons to a solvent along with metal salts. It is proposed that the film be formed by However, as clearly shown in the examples, these methods have relatively large pore diameters,
Most of the membranes have a diameter of 0.1μ or more, and this method is not necessarily suitable for producing membranes for collecting albumin. <Object of the Invention> The present invention aims to obtain a hollow fiber membrane for recovering albumin from the plasma of such patients. That is, the purpose of the present invention is to efficiently recover albumin from plasma by adjusting the average pore diameter to approximately 0.01μ.
It is an object of the present invention to provide a method for advantageously producing cellulose ester hollow fiber membranes having a diameter of ~0.1μ, more preferably approximately 0.02μ to approximately 0.07μ. <Structure of the Invention> As a result of intensive research to achieve the above object, the present inventors found that a specific organic compound added to the spinning stock solution together with a solvent and the pores of the cellulose ester hollow fiber membrane obtained are unique. It was found that there is a relationship between
It was discovered that a hollow fiber membrane with excellent albumin permeability of about 0.1μ can be obtained very advantageously, and the present invention was achieved. That is, the present invention is based on the following general formula () [However, in formula (), R 1 and R 2 are the same or different and represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 3 is a hydrogen atom,
【式】(ここ
でR4及びR5は、同一又は異なり水素原子又は炭
素数が1〜3であるアルキル基を示す。)で表わ
されるアミノ基又は炭素数が1〜3であるアルキ
ル基を表わし、R1とR3が共にアルキル基である
場合には互いに共同して環を形成してもよい。〕
で示される含窒素化合物の少なくとも1種を10〜
40重量%、セルロースアセテートを主成分とする
セルロースエステルを15〜25重量%、2価の金属
塩を0.1〜5重量%、及びケトンと低級アルコー
ルの混合溶媒を30〜74.9重量%含有した紡糸原液
を用いて湿式紡糸することを特徴とする血漿アル
ブミン選択透過性中空糸膜の製造法を提供するも
のである。
以下、本発明についてさらに詳細に説明する。
本発明におけるセルロースエステルとは、セル
ロースジアセテート、セルローストリアセテート
等のセルロースアセテート類、ニトロセルロース
類等を意味し、好ましくはセルロースアセテート
が主成分として用いられる。尚、本発明では、か
かる主成分のセルロースアセテート以外の成分と
して、セルロースエステル以外の本発明紡糸原液
に可溶の高分子化合物を用いることもできる。
また前記一般式()で示される含窒素化合物
としては、例えばホルムアミド、ジメチルホルム
アミド、N−ジメチルアセトアミド、プロピオン
アミド等の鎖状アミド類、N−メチルピロリド
ン、ε−カプロラクタム、γ−パレロラクタム、
α−ピペリドン等の環状アミド、及び尿素、ジメ
チル尿素、テトラメチル尿素、ジエチル尿素等の
尿素類等が挙げられる。かかる式()で示され
る含窒素化合物の中でも、ホルムアミド、ジメチ
ルホルムアミド、N−メチルピロリドン、ε−カ
プロラクタム及び尿素が好ましい。
また本発明におけるケトンとしては炭素数が3
〜5のケトンであつて、好ましいものとしてはア
セトン、メチルエチルケトン等が挙げられる。さ
らに本発明の低級アルコールとは、炭素数が2〜
5の1価のアルコールであつて、好ましくは、メ
タノール、エタノール等である。本発明の2価の
金属塩としては、塩化カルシウム、塩化マグネシ
ウム等が好ましい。かかるケトン、低級アルコー
ル及び塩類は、各々2種以上用いてもよいが、通
常は各々1種で用いられる。
本発明の製造法としては好ましくは、例えばセ
ルロースアセテートを主成分とした高分子化合物
とアセトン−メタノール混合溶媒に、該高分子の
酢酸基と親和性を有すると考えられる前記一般式
()の窒素含有化合物を加え、さらに塩化カル
シウムを添加して調整された紡糸原液を用いて、
湿式紡糸をするものである。
かかる本発明の紡糸原液には、紡糸粘度等の紡
糸安定性及び中空糸膜性能の点から前記セルロー
スアセテート等の高分子が15〜25重量%の範囲で
含有されることが好ましい。
該紡糸原液中に含有せしめる2価の金属塩、例
えば塩化カルシウムの濃度は、得られる中空糸膜
の細孔径を調節するために0.1〜5.0重量%の範囲
が好ましく、さらに1.0〜3.0重量%の範囲が望ま
しい。かかる塩化カルシウム濃度を少なくするこ
とにより、細孔径の小さい中空糸膜が得やすい。
また該紡糸原液に含有せしめる前記式()の
含窒素化合物の濃度は、中空糸膜の細孔径に大き
くすることから、10〜40重量%の範囲が好まし
く、特に20〜30重量%が望ましい。
さらに該紡糸原液中のケトンと低級アルコール
の混合重量比としては、高分子の溶解性、紡糸安
定性等の点でケトン/低級アルコールが2.5/1
〜4/1の範囲にあることが好ましい。尚、該紡
糸原液には、紡糸性、中空糸膜性能に悪影響を及
ぼさない範囲で水その他の成分を含有せしめても
よい。
かかる紡糸原液の調製法としては、在来公知の
いかなる方法によつてもよいが、例えば高分子化
合物に含窒素化合物を添加しよく撹拌混合した
後、塩化カルシウム2水塩のメタノール溶液を添
加混合し、次いでアセトンを加えて撹拌しながら
5時間以上溶解を行なわしめ、さらに必要に応じ
て過などの後処理を行なう方法が用いられる。
本発明は、この様にして得られた紡糸原液を用
いて環状ノズルにより湿式紡糸を行なうものであ
る。環状ノズルとしては、所定の中空糸膜が得ら
れるものであればいかなるものであつてもよい。
該湿式紡糸を行なう際に使用する中空糸外部の凝
固液及び中空糸内部の凝固液としては、水−低級
アルコール、水−ケトン、水−低級アルコール−
ケトン等の混合液系を用いるのが好ましく、前記
式()で示される含窒素化合物、塩化カルシウ
ム等の塩類その他の化合物が含まれていてもよ
い。
かかる本発明の中空糸膜の製造法において、中
空糸外部の凝固液と中空糸内部の凝固液の各々の
組成を調製することにより、平均細孔を制御する
ことも可能であり、その製法の仕方によつては中
空糸膜の内側と外側で緻密さが異なる所謂異方性
の中空糸膜を得ることもできる。即ち凝固速度の
より大きい凝固液を用いて他の側より緻密な構造
として異方性を形成せしめることができる。
この様な本発明の製造法によつて得られる中空
糸膜は、その平均細孔径が約0.01μ〜約0.1μの範
囲、より好ましくは約0.02μ〜約0.07μの範囲にあ
つて、血漿中のアルブミンの選択透過性が高い特
性を有するものである。
以下実施例をあげてさらに詳細に説明するが、
本発明はこれらの実施例によつて何ら限定される
ものではない。尚、実施例中、「部」は「重量部」
を意味する。さらに実施例中の中空糸膜の平均細
孔径の測定は、以下に示す水透過法なる簡便法に
よつて行なつた。
即ち、一定量の水を透過させ、その流速と圧力
損失を測定することで次式により算出した。
D2=32y・d・j/Pr・△P
但しD:平均細孔径
d:膜厚
J:水の透過速度
y:水の粘度
Pr:中空糸膜の空孔率
△P:圧力損失
をそれぞれ意味する。
実施例 1
酢化度52%の酢酸セルロース18.5重量%、ホル
ムアミド20重量%、尿素10重量%、CaCl2・
2H2O2重量%、アセトン/メタノール(3/1)
49.5重量%の組成のドープを作成し、過後、環
状ノズルを用いて湿式紡糸を行なつた。
凝固浴組成は水−メタノール−アセトン(50:
40:10)であり、中空糸の内部凝固液は水−エタ
ノール−ホルムアミド(50:40:10)である。
内径200μ、膜厚70μの中空糸が得られ、細孔の
孔径は400〓であつた。
得られた中空糸を用いて外表面積で1m2となる
様に両端をポリウレタンで固定して中空糸型分離
器を作成した。この分離器に1当り5000単位の
ペパリンを含有した牛血漿を中空糸の内側から外
側に透過するように過実験を37℃で1時間行な
つた。尚その際の透過量を20ml/minとし、100
ml/minの部分循環法を用いた。運転時間1時間
目における血漿原液中、及び透過液中のアルブミ
ン及びイムノグロブリンMの分析を行なつた。そ
の結果アルブミンの透過率は90%、イムノグロブ
リンMの透過は41%であつた。
実施例 2
酢化度52%の酢酸セルロース185部にホルムア
ミド250部添加し、更にCaCl2・2H2O 10部溶解
したメタノール150部加え混合した後、アセトン
405部を加え撹拌溶解すると酢酸セルロース18.5
重量%、ホルムアミド25重量%、CaCl2・2H2O
1重量%、アセトン−メタノール5.5重量%の紡
糸原液が作成出来る。過後環状ノズルを用いて
中空糸を紡糸した。尚凝固液としては実施例1と
同じ組成のものを用いた。内径300μ、肉厚80μの
中空糸が得られ、その細孔の孔径は350Åであつ
た。
実施例 3
酢化度52%の酢酸セルロースを用いて、紡糸原
液組成を次の様に作成した。即ち酢酸セルロース
20重量%、N−メチルピロリドン25重量%、
CaCl2・2H2O 3重量%、アセトン/メタノール
(3/1)52重量%の組成の紡糸原液を過後、
環状ノズルを用いて湿式紡糸し、内径300μ、肉
厚50μの中空糸が得られ、その細孔の孔径は450
Åであつた。
実施例 4
酢化度52%の酢酸セルロース90重量%、硝化度
12%の硝酸セルロース10重量%の混合セルロース
エステル18.5重量%、ホルムアミド25重量%、
CaCl2・2H2O 3重量%、アセトン/メタノール
(3/1)55.5重量%の組成のドープを作成し、
過後環状ノズルを用い、実施例1と同じ凝固液
等を用いて湿式紡糸を行なつた。内径250μ、肉
厚60μの中空糸が得られ、細孔の孔径は300Åで
あつた。
比較例 1
実施例2ほ原液と同様に酢酸セルロース18.5重
量%、ホルムアミド25重量%、重量比が3:1の
アセトン−メタノール56.5重量%とし、CaCl2・
2H2Oを用いない原液を作成し、中空糸を紡糸
し、内径300μ、肉厚80μの中空糸が得られたが、
その細孔の孔径は60Å程度であり、アルブミンの
透過性は殆んど認められなかつた。
比較例 2
ホルムアミドを用いない以外は実施例2の原液
と同様に原液を調製して、酢酸セルロース18.5重
量%、CaCl2・2H2O 1重量%、アセトン−メタ
ノール溶液80.5重量%の原液を作成し、中空糸を
紡糸し、内径300μ、肉厚80μの中空糸が得られ
た。その細孔の孔径は1000Å程度と大きく、アル
ブミンの透過性は100%、イムノグロブリンMの
透過性も80%以上となり、良好なアルブミンの選
択透過性は得られなかつた。
<発明の効果>
本願発明によつて、血漿中のアルブミンを回収
するためのアルブミン透過性中空糸膜が非常に容
易に得られる。即ち、本発明によればアルミンほ
選択的透過に適した平均細孔径を有する中空糸膜
が非常に安定に且つ容易に得られる。
特に本発明の効果としては、平均細孔径が約
0.01〜0.1μの範囲で、特に002〜0.07μの範囲で中
空糸製造条件の調整によつてその細孔径を容易に
制御しうることが挙げられる。[Formula] (where R 4 and R 5 are the same or different and represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms) or an alkyl group having 1 to 3 carbon atoms. When R 1 and R 3 are both alkyl groups, they may cooperate with each other to form a ring. ] At least one nitrogen-containing compound represented by 10 to
A spinning stock solution containing 40% by weight, 15 to 25% by weight of cellulose ester mainly composed of cellulose acetate, 0.1 to 5% by weight of divalent metal salt, and 30 to 74.9% by weight of a mixed solvent of ketone and lower alcohol. The present invention provides a method for producing a hollow fiber membrane selectively permeable to plasma albumin, which is characterized by performing wet spinning using a plasma albumin permselective membrane. The present invention will be explained in more detail below. The cellulose ester in the present invention refers to cellulose acetates such as cellulose diacetate and cellulose triacetate, nitrocellulose, etc., and preferably cellulose acetate is used as the main component. In the present invention, as a component other than cellulose acetate as the main component, a polymer compound soluble in the spinning dope of the present invention other than cellulose ester can also be used. Examples of the nitrogen-containing compound represented by the general formula () include linear amides such as formamide, dimethylformamide, N-dimethylacetamide, and propionamide, N-methylpyrrolidone, ε-caprolactam, γ-parerolactam,
Examples include cyclic amides such as α-piperidone, and ureas such as urea, dimethylurea, tetramethylurea, and diethylurea. Among the nitrogen-containing compounds represented by the formula (), formamide, dimethylformamide, N-methylpyrrolidone, ε-caprolactam and urea are preferred. In addition, the ketone in the present invention has 3 carbon atoms.
-5 ketones, and preferred ones include acetone, methyl ethyl ketone, and the like. Furthermore, the lower alcohol of the present invention has 2 to 2 carbon atoms.
5 monohydric alcohol, preferably methanol, ethanol, etc. As the divalent metal salt of the present invention, calcium chloride, magnesium chloride, etc. are preferred. Two or more types of each of these ketones, lower alcohols, and salts may be used, but usually one type of each is used. Preferably, in the production method of the present invention, for example, a polymer compound mainly composed of cellulose acetate and an acetone-methanol mixed solvent are added with nitrogen of the general formula () that is considered to have an affinity for the acetate group of the polymer. Using a spinning stock solution prepared by adding containing compounds and further adding calcium chloride,
It uses wet spinning. The spinning dope of the present invention preferably contains a polymer such as cellulose acetate in an amount of 15 to 25% by weight from the viewpoint of spinning stability such as spinning viscosity and hollow fiber membrane performance. The concentration of a divalent metal salt, such as calcium chloride, contained in the spinning stock solution is preferably in the range of 0.1 to 5.0% by weight, and more preferably in the range of 1.0 to 3.0% by weight, in order to control the pore diameter of the hollow fiber membrane obtained. Range is preferred. By reducing the calcium chloride concentration, hollow fiber membranes with small pore diameters can be easily obtained. Further, the concentration of the nitrogen-containing compound of formula () contained in the spinning dope is preferably in the range of 10 to 40% by weight, particularly preferably 20 to 30% by weight, in order to increase the pore diameter of the hollow fiber membrane. Furthermore, the mixing weight ratio of ketones and lower alcohols in the spinning dope is 2.5/1 in terms of polymer solubility, spinning stability, etc.
It is preferable that it is in the range of ~4/1. Note that the spinning dope may contain water and other components within a range that does not adversely affect the spinnability and hollow fiber membrane performance. The spinning stock solution may be prepared by any conventionally known method, but for example, a nitrogen-containing compound is added to a polymer compound, the mixture is well stirred, and then a methanol solution of calcium chloride dihydrate is added and mixed. Then, acetone is added and dissolved for 5 hours or more while stirring, and if necessary, post-treatment such as filtration is performed. In the present invention, wet spinning is carried out using a spinning dope obtained in this way using an annular nozzle. Any annular nozzle may be used as long as a predetermined hollow fiber membrane can be obtained.
The coagulating liquid outside the hollow fibers and the coagulating liquid inside the hollow fibers used in the wet spinning include water-lower alcohol, water-ketone, water-lower alcohol-
It is preferable to use a mixed liquid system of ketones, etc., and may contain a nitrogen-containing compound represented by the above formula (), salts such as calcium chloride, and other compounds. In the method for manufacturing a hollow fiber membrane of the present invention, it is also possible to control the average pores by adjusting the composition of the coagulating liquid outside the hollow fiber and the coagulating liquid inside the hollow fiber, and the manufacturing method Depending on the method, it is also possible to obtain a so-called anisotropic hollow fiber membrane in which the density differs between the inside and outside of the hollow fiber membrane. That is, by using a coagulating liquid with a higher solidifying rate, it is possible to form an anisotropic structure with a denser structure than that on the other side. The hollow fiber membrane obtained by the production method of the present invention has an average pore diameter in the range of about 0.01μ to about 0.1μ, more preferably in the range of about 0.02μ to about 0.07μ. It has a characteristic of high selective permeability of albumin therein. This will be explained in more detail by giving examples below.
The present invention is not limited in any way by these Examples. In the examples, "part" means "part by weight"
means. Furthermore, the average pore diameter of the hollow fiber membranes in the Examples was measured by a simple method called the water permeation method described below. That is, it was calculated by the following formula by passing a certain amount of water and measuring the flow rate and pressure loss. D 2 = 32y・d・j/Pr・△P where D: average pore diameter d: membrane thickness J: water permeation rate y: viscosity of water Pr: porosity of hollow fiber membrane △P: pressure loss, respectively means. Example 1 18.5% by weight of cellulose acetate with a degree of acetylation of 52%, 20% by weight of formamide, 10% by weight of urea, CaCl2 .
2H 2 O2 wt%, acetone/methanol (3/1)
A dope having a composition of 49.5% by weight was prepared, and after filtration, wet spinning was performed using an annular nozzle. The coagulation bath composition was water-methanol-acetone (50:
40:10), and the internal coagulating liquid of the hollow fiber is water-ethanol-formamide (50:40:10). A hollow fiber with an inner diameter of 200 μm and a membrane thickness of 70 μm was obtained, and the pore diameter was 400 μm. Using the obtained hollow fibers, both ends were fixed with polyurethane so that the outer surface area was 1 m 2 to prepare a hollow fiber separator. An overexperiment was conducted at 37° C. for 1 hour so that bovine plasma containing 5,000 units of pepperin per separator permeated from the inside to the outside of the hollow fiber. In addition, the permeation amount at that time is 20ml/min, and 100
A partial circulation method of ml/min was used. Albumin and immunoglobulin M were analyzed in the plasma stock solution and the permeate during the first hour of operation. As a result, the permeability of albumin was 90% and that of immunoglobulin M was 41%. Example 2 250 parts of formamide was added to 185 parts of cellulose acetate with a degree of acetylation of 52%, and 150 parts of methanol in which 10 parts of CaCl 2.2H 2 O was dissolved were added and mixed, followed by acetone.
When 405 parts were added and dissolved with stirring, cellulose acetate was 18.5 parts.
wt%, formamide 25 wt% , CaCl2.2H2O
A spinning stock solution containing 1% by weight and 5.5% by weight of acetone-methanol can be prepared. After spinning, hollow fibers were spun using an annular nozzle. The coagulating liquid used had the same composition as in Example 1. A hollow fiber with an inner diameter of 300 μm and a wall thickness of 80 μm was obtained, and the pore diameter thereof was 350 Å. Example 3 Using cellulose acetate with a degree of acetylation of 52%, a spinning stock solution composition was prepared as follows. i.e. cellulose acetate
20% by weight, N-methylpyrrolidone 25% by weight,
After passing through a spinning stock solution with a composition of 3% by weight of CaCl 2 2H 2 O and 52% by weight of acetone/methanol (3/1),
By wet spinning using an annular nozzle, hollow fibers with an inner diameter of 300 μm and a wall thickness of 50 μm were obtained, and the pore diameter was 450 μm.
It was Å. Example 4 Cellulose acetate 90% by weight with a degree of acetylation of 52%, degree of nitrification
12% cellulose nitrate, 10% by weight, mixed cellulose esters 18.5% by weight, formamide 25% by weight,
A dope with a composition of 3% by weight of CaCl 2 2H 2 O and 55.5% by weight of acetone/methanol (3/1) was prepared.
Wet spinning was carried out using the same coagulating liquid as in Example 1 using a post-filtering annular nozzle. A hollow fiber with an inner diameter of 250 μm and a wall thickness of 60 μm was obtained, and the pore diameter was 300 Å. Comparative Example 1 Same as in Example 2, 18.5% by weight of cellulose acetate, 25% by weight of formamide, 56.5% by weight of acetone-methanol at a weight ratio of 3:1, and CaCl2 .
A stock solution without 2H 2 O was prepared and hollow fibers were spun to obtain hollow fibers with an inner diameter of 300μ and a wall thickness of 80μ.
The pore diameter was approximately 60 Å, and almost no albumin permeability was observed. Comparative Example 2 A stock solution was prepared in the same manner as in Example 2 except that formamide was not used to create a stock solution containing 18.5% by weight of cellulose acetate, 1% by weight of CaCl 2 2H 2 O, and 80.5% by weight of acetone-methanol solution. Then, the hollow fibers were spun to obtain hollow fibers with an inner diameter of 300μ and a wall thickness of 80μ. The pore diameter was as large as about 1000 Å, and the permeability of albumin was 100% and the permeability of immunoglobulin M was also 80% or more, so that good permselectivity for albumin could not be obtained. <Effects of the Invention> According to the present invention, an albumin-permeable hollow fiber membrane for recovering albumin in plasma can be obtained very easily. That is, according to the present invention, a hollow fiber membrane having an average pore diameter suitable for selective permeation of aluminium can be obtained very stably and easily. In particular, the effect of the present invention is that the average pore diameter is approximately
The pore diameter can be easily controlled within the range of 0.01 to 0.1μ, particularly within the range of 0.02 to 0.07μ, by adjusting the hollow fiber manufacturing conditions.
Claims (1)
異なり水素原子又は炭素数が1〜3であるアルキ
ル基を表わし、R3は水素原子、【式】(ここ でR4及びR5は、同一又は異なり水素原子又は炭
素数が1〜3であるアルキル基を示す。)で表わ
されるアミノ基又は炭素数が1〜3であるアルキ
ル基を表わし、R1とR3が共にアルキル基である
場合には互いに共同して環を形成してもよい。〕 で示される含窒素化合物の少なくとも1種を10〜
40重量%、セルロースアセテートを主成分とする
セルロースエステルを15〜25重量%、2価の金属
塩を0.1〜5重量%、及びケトンと低級アルコー
ルの混合溶媒を30〜74.9重量%含有した紡糸原液
を用いて湿式紡糸することを特徴とする血漿アル
ブミン選択透過性中空糸膜の製造法。[Claims] 1 The following general formula (I) [However, in formula (), R 1 and R 2 are the same or different and represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 3 is a hydrogen atom, [Formula] (where R 4 and R 5 are , which are the same or different and represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms. In some cases, they may cooperate with each other to form a ring. ] At least one nitrogen-containing compound represented by 10 to
A spinning stock solution containing 40% by weight, 15 to 25% by weight of cellulose ester mainly composed of cellulose acetate, 0.1 to 5% by weight of divalent metal salt, and 30 to 74.9% by weight of a mixed solvent of ketone and lower alcohol. A method for producing a hollow fiber membrane selectively permeable to plasma albumin, which comprises performing wet spinning using a plasma albumin selectively permeable hollow fiber membrane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10763483A JPS60806A (en) | 1983-06-17 | 1983-06-17 | Manufacture of plasma albumin permeable hollow yarn membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10763483A JPS60806A (en) | 1983-06-17 | 1983-06-17 | Manufacture of plasma albumin permeable hollow yarn membrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60806A JPS60806A (en) | 1985-01-05 |
| JPH0318492B2 true JPH0318492B2 (en) | 1991-03-12 |
Family
ID=14464158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10763483A Granted JPS60806A (en) | 1983-06-17 | 1983-06-17 | Manufacture of plasma albumin permeable hollow yarn membrane |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60806A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986002575A1 (en) * | 1984-10-30 | 1986-05-09 | Teijin Limited | Permselective hollow yarn membrane, method of producing the same, method of separating plasma components, and plasma component separator |
| US4744932A (en) * | 1985-05-31 | 1988-05-17 | Celanese Corporation | Process for forming a skinless hollow fiber of a cellulose ester |
| JPS6277325A (en) * | 1985-09-30 | 1987-04-09 | Asahi Chem Ind Co Ltd | Membrane separation of albumin |
| JP2006083292A (en) * | 2004-09-16 | 2006-03-30 | Fuji Photo Film Co Ltd | Method for stable production of microporous membrane and use thereof in nucleic acid separation and purification method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5411322A (en) * | 1977-06-29 | 1979-01-27 | Asahi Chem Ind Co Ltd | Hollow cellulose fibers and their production |
| JPS5643415A (en) * | 1979-09-13 | 1981-04-22 | Nippon Zeon Co Ltd | Production of hollow fiber |
| DE3006880C2 (en) * | 1980-02-23 | 1986-10-09 | Akzo Gmbh, 5600 Wuppertal | Plasmaphoresis membrane |
| JPS57210010A (en) * | 1981-06-19 | 1982-12-23 | Teijin Ltd | Production of porous hollow fiber membrane |
-
1983
- 1983-06-17 JP JP10763483A patent/JPS60806A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60806A (en) | 1985-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0201604B1 (en) | Permselective hollow yarn membrane, method of producing the same, method of separating plasma components, and plasma component separator | |
| AU672856B2 (en) | High flux hollow fiber membrane | |
| EP0012630B1 (en) | Process for producing a cellulose acetate-type permselective membrane, permselective membrane thus produced, and use of such membrane in artificial kidney | |
| JP2542572B2 (en) | Hollow fiber | |
| JPH0318492B2 (en) | ||
| JPH053335B2 (en) | ||
| JPS5938805B2 (en) | Manufacturing method of semipermeable membrane with selective permselectivity | |
| JPH10216489A (en) | Cellulose hollow fiber membrane and its production | |
| CA2093619A1 (en) | Hollow fiber membrane for blood purification | |
| JP3020016B2 (en) | Hollow fiber membrane | |
| JP3424807B2 (en) | Hollow fiber membrane | |
| JPH0120245B2 (en) | ||
| JPH0375205B2 (en) | ||
| JP4381022B2 (en) | Hollow fiber blood purification membrane | |
| JP3205268B2 (en) | Method for producing selectively permeable hollow fiber membrane | |
| JP2501933B2 (en) | Copper-ammonia method regenerated cellulose hollow fiber and method for producing the same | |
| JPH0712421B2 (en) | Method for producing hollow fiber membrane made of polysulfone | |
| JP2000210544A (en) | Production of semipermeable membrane | |
| JP2000107577A (en) | Method for producing permselective hollow fiber membrane | |
| JPH0566169B2 (en) | ||
| JPS5841883B2 (en) | Plasma separation membrane and its manufacturing method | |
| JP2818355B2 (en) | Manufacturing method of hollow fiber membrane | |
| JP3205267B2 (en) | Method for producing selectively permeable hollow fiber membrane | |
| JPS60193504A (en) | Hollow fiber membrane for dialysis | |
| JPS6391124A (en) | Porous hollow fiber membrane and its manufacturing method |